Eli Lilly's Mounjaro Approved for Weight Loss in the U.S. 0 08.11.2023 21:01 The Wall Street Journal The drug, which will be sold as Zepbound as an anti-obesity treatment, had previously been cleared by the FDA for the treatment of Type 2 diabetes. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
